S. 27, The Preserve Access to Affordable Generics Act (4 wiki edits)
- This item is from the 112th Congress (2011-2012) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
- This bill, or a similar bill, was reintroduced in the current Congress as S. 214, The Preserve Access to Affordable Generics Act.
S. 27 would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
()
[36 views]
Saves: $ per
and decreases their $ share of the national debt by $.
(source: Congressional Budget Office)
Learn More
Visitor Comments
There are currently no comments for this bill
RSS Feeds for This Bill
Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)
From the Blog
WashingtonWatch.com Digest – November 14, 2011
This is the WashingtonWatch.com email newsletter for the week of November 14, 2011. Subscribe (free!) here. email newsletter | tell a friend | wiki | about | home | log in On the Blog: A Budget Amendment, But No Budget Congress plans to take up a balan...